Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

被引：0
|
作者：
Omar Eton
Merrick I Ross
Mary Jo East
Paul F Mansfield
Nicholas Papadopoulos
Julie A Ellerhorst
Agop Y Bedikian
Jeffrey E Lee
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Melanoma Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Translational Medicine | / 8卷
关键词：
Melanoma; Major Histocompatibility Complex Class; Adjuvant Setting; ELISPOT Assay; Autologous Tumor Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Long-term evaluation of patients (Pts) with malignant melanoma (MM) treated with autologous cancer vaccine HSPPC-96 at three different dose levels.
    Camacho, LH
    Hawkins, KA
    Ross, MI
    Savary, C
    Bedikian, AY
    Lee, JE
    Papadopoulos, NE
    Gupta, R
    Srivastava, PK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 722S - 722S
  • [32] A Phase 2 Multicenter Trial of Autologous Heat Shock Protein-Peptide Vaccine (HSPPC-96) for Recurrent Glioblastoma Multiforme (GBM) Patients Shows Improved Survival Compared to a Contemporary Cohort Controlled for Age, KPS and Extent of Resection
    Parsa, Andrew Thomas
    Crane, Courtney
    Han, Seunggu J.
    Kivett, Valerie
    Fedoroff, Anne
    Butowski, Nicholas
    Chang, Susan
    Prados, Michael
    Clarke, Jennifer
    Berger, Mitchel S.
    McDermott, Michael W.
    Aghi, Manish K.
    Sloan, Andrew E.
    Bruce, Jeffrey N.
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A406 - A406
  • [33] MOLECULAR HETEROGENEITY OF TUMOR REJECTION ANTIGEN HEAT-SHOCK PROTEIN GP96
    FELDWEG, AM
    SRIVASTAVA, PK
    INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) : 310 - 314
  • [34] T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma
    Zhang, Yang
    Mudgal, Poorva
    Wang, Liuyang
    Wu, Haiyang
    Huang, Na
    Alexander, Peter B.
    Gao, Zhixian
    Ji, Nan
    Li, Qi-Jing
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [35] Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells
    Rivoltini, L
    Castelli, C
    Carrabba, M
    Mazzaferro, V
    Pilla, L
    Huber, V
    Coppa, J
    Gallino, G
    Scheibenbogen, C
    Squarcina, P
    Cova, A
    Camerini, R
    Lewis, JJ
    Srivastava, PK
    Parmiani, G
    JOURNAL OF IMMUNOLOGY, 2003, 171 (07): : 3467 - 3474
  • [36] EVIDENCE FOR BIOCHEMICAL HETEROGENEITY OF GP96 HEAT-SHOCK PROTEIN TUMOR REJECTION ANTIGEN
    FELDWEG, AM
    SRIVASTAVA, PK
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 108 - 108
  • [37] An autologous tumor-derived heat shock protein vaccine for high risk ovarian cancer
    Li, Z
    Nash, JD
    Qiao, Y
    Kulko, JM
    Wilcox, DK
    Gaffney, J
    Runowicz, CD
    Simonich, SA
    Liu, B
    Srivastava, PK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 859S - 859S
  • [38] Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96
    Janetzki, S
    Blachere, NE
    Srivastava, PK
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04): : 269 - 276
  • [39] Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation
    Wen-Wen Lu
    Hong Zhang
    You-Ming Li
    Feng Ji
    World Journal of Gastroenterology, 2017, (24) : 4390 - 4398
  • [40] Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation
    Lu, Wen-Wen
    Zhang, Hong
    Li, You-Ming
    Ji, Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (24) : 4390 - 4398
12345